Novo Nordisk Stock Slipped 3.3% ThursdayNovo Nordisk ( NYSE:NVO ) stands as a beacon of innovation, continually pushing boundaries in the treatment of diabetes and obesity. However, despite its recent successes, the company finds itself navigating the delicate balance between bullish growth projections and meeting market expectations.
Th